Graeme Jarvis: Medicines NZ CEO on the impact of the $1.7 billion funding boost for Pharmac

Pharmac's record funding-boost will fill a fiscal hole to ensure it can keep funding the treatments currently on offer.  The drug-buying agency is being promised an additional $1.7 billion over four years in the upcoming Budget.  Medicines NZ Chief Executive, Graeme Jarvis told Mike Hosking that without it, some patients would have lost out on medicines paid for by time-limited funding.  He says while it sounds like a lot of money, it's being spread over four years and simply keeps things as they are.  LISTEN ABOVE   See omnystudio.com/listener for privacy information.